Senti Biosciences is trading at $0.21, up 12.59%, with no clear company-specific catalyst identified for the October 28 move.
- The company recently disclosed an October 30 record date for its previously announced CVR distribution and a director’s resignation; available reporting does not establish either as the cause.
- Biotech shares are higher, with the XBI up 2.18%, while the broader market is nearly flat. The move’s specific driver remains uncertain.